Index of reports
> Cases with Dyspnoea (146)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 146 Next >>
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: White Blood Cell Count Decreased, Dyspnoea, Pruritus Generalised, Fatigue, Dysphonia, Depressed Mood, RED Blood Cell Count Abnormal, Cough
Drug(s) suspected as cause:
Pegasys
Dosage: 180 microgram, unk
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 4 df, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-01
Victrelis
Dosage: 200 mg, tid
Other drugs received by patient: Pravastatin Sodium; Ambien; Prozac; Vitamin D; Trazodone HCL; Cholecalciferol; Levoxyl; Epoetin Alfa; Neupogen
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Injection Site Erythema, Dyspnoea, Fatigue, Pruritus, Rash Erythematous, Rash, Thyroid Function Test Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Possible Ribavirin side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-08-23
Patient: 47 year old female
Reactions: Weight Decreased, Angiotensin Converting Enzyme Increased, Subcutaneous Nodule, Aphasia, Coma, Viith Nerve Paralysis, Brain Oedema, Sarcoidosis, Acute Respiratory Failure, Lethargy, Dyspnoea, Neurological Decompensation, Lung Neoplasm, Sensation of Heaviness, Rash, Granuloma, Lymphadenopathy Mediastinal, Cerebral Sarcoidosis, Pleocytosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 ug, once a week
Ribavirin
Dosage: 400 mg, bid
Indication: Hepatitis C
Other drugs received by patient: Prednisolone; Prednisolone; Methylprednisolone
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash Erythematous, Rash, Thyroid Function Test Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Metabolic Acidosis, Dyspnoea, Diarrhoea, Hypophagia, Bronchitis, Pyrexia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Boceprevir
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded MK-5172
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded Post Trial Therapy
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded PRE Trial Therapy
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: f
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: h
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: c
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: g
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: e
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: d
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: b
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: 4 df, tid
Administration route: Oral
Start date: 2012-02-08
End date: 2012-06-24
Blinded Therapy
Blinded Therapy
Blinded Therapy
Blinded Therapy
Indication: Hepatitis C
Blinded Therapy
PEG-Intron
Indication: Hepatitis C
PEG-Intron
Dosage: 0.5 ml, qw
Administration route: Oral
Start date: 2012-01-10
End date: 2012-06-19
Peginterferon Alfa-2B
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Placebo
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Rebetol
Dosage: 3 df, qam
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-10
Rebetol
Dosage: 3 df, qpm
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-06
Rebetol
Dosage: 2 df, qpm
Administration route: Oral
Start date: 2012-04-07
End date: 2012-06-24
Rebetol
Dosage: 2 df, qam
Administration route: Oral
Start date: 2012-05-01
End date: 2012-06-24
Rebetol
Dosage: 3 df, qam
Administration route: Oral
Start date: 2012-04-17
End date: 2012-04-30
Rebetol
Dosage: 2 df, qam
Administration route: Oral
Start date: 2012-04-11
End date: 2012-04-16
Ribavirin
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Other drugs received by patient: Protonix; Paxil; Protonix; Lisinopril; Paxil; Lisinopril
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Weight Increased, Dysgeusia, Dyspnoea, Fatigue, Nausea, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-18
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2011-12-26
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-08-24
End date: 2011-12-23
Other drugs received by patient: Methotrexate
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Ileus
Adverse event resulted in: death
Drug(s) suspected as cause:
Cozaar
Indication: Product Used FOR Unknown Indication
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Incivek
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-20
Patient: female
Reactions: Staphylococcal Skin Infection, Cellulitis, Viral Load Increased, Dyspnoea, Arthropathy, Renal Failure, Alopecia, Abscess, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Indication: Hepatitis C
Start date: 2012-02-03
Pegasys
Indication: Hepatitis C
Start date: 2012-02-03
Ribavirin
Indication: Hepatitis C
Start date: 2012-02-03
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Dyspnoea, Nausea, Diabetes Mellitus, Hypotension, Anaemia, Rash, Headache, Therapeutic Product Ineffective, Dysgeusia, Fatigue, RED Blood Cell Count Decreased, Asthenia, Lethargy, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
PEG-Intron
Dosage: unk unk, unknown
Start date: 2011-08-17
End date: 2012-04-03
PEG-Intron
Dosage: unk unk, unknown
End date: 2009-10-07
PEG-Intron
Dosage: 0.4 ?g, unknown
PEG-Intron
Dosage: 0.3 ?g, unknown
Ribavirin
Dosage: unk unk, unknown
End date: 2009-10-07
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
Ribavirin
Dosage: 200 mg, qd
Ribavirin
Dosage: unk unk, qd
Ribavirin
Dosage: unk unk, qd
Start date: 2011-08-17
End date: 2012-04-03
Ribavirin
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Other drugs received by patient: Epoetin Alfa
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-13
Patient: female
Reactions: Blood Iron Decreased, Drug Dose Omission, Dyspnoea, RED Blood Cell Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Indication: Hepatitis C
Start date: 2012-07-05
Ribavirin
Indication: Hepatitis C
Start date: 2012-07-05
Telaprevir
Indication: Hepatitis C
Start date: 2012-07-05
Other drugs received by patient: Warfarin Sodium; Fluoxetine HCL; Metformin Hydrochloride; Bisacodyl; Trazodone Hydrochloride; Ferrous Sulfate TAB
Possible Ribavirin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-10
Patient: female, weighing 72.5 kg (159.5 pounds)
Reactions: Dyspnoea, Rash, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-05-07
Placebo
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-18
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
VX-950
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-18
Other drugs received by patient: Metrogel; Equate Allergy Relief; Tylenol; Multi-Vitamins; Tramadol HCL; Gold Bond Intensive Healing Cream; GAS-X
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from Germany on 2012-08-10
Patient: male
Reactions: Dyspnoea, Chills, Headache, Somnolence, Cardiac Disorder, Apathy, Memory Impairment, Asthenia
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-06-01
Ribavirin
Indication: Hepatitis C
Start date: 2012-06-01
Telaprevir
Indication: Hepatitis C
Start date: 2012-06-01
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Abdominal Pain, Dyspnoea, Ileus
Adverse event resulted in: death
Drug(s) suspected as cause:
Cozaar
Indication: Product Used FOR Unknown Indication
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Telaprevir
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient:
Reactions: Dyspnoea, Fatigue
Drug(s) suspected as cause:
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-01
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-01
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-01
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Dyspnoea, Nausea, Palpitations, DRY Mouth, Decreased Appetite
Drug(s) suspected as cause:
Pegasys
Ribavirin
Dosage: 1200, qd
Victrelis
Dosage: 200 mg, unk
Other drugs received by patient: Prednisone
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-11-23
Possible Ribavirin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-03
Patient: female, weighing 72.5 kg (159.5 pounds)
Reactions: Dyspnoea, Rash, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-05-07
Placebo
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-18
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
VX-950
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-18
Other drugs received by patient: Tylenol (Caplet); Tramadol HCL; Equate Allergy Relief; Metrogel; Multi-Vitamins; GAS-X; Gold Bond Intensive Healing Cream
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: female
Reactions: Abdominal Pain, Thrombosis, Pruritus, Lymphadenopathy, Injection Site Haematoma, Hallucination, Auditory, Tooth Extraction, Headache, Appetite Disorder, Malaise, Menorrhagia, Skin Warm, Muscle Spasms, Blister, Crying, Back Pain, Stomatitis, Rash Erythematous, Insomnia, Swelling, Vision Blurred, Thyroid Disorder, Pain, Constipation, Fatigue, Chest Pain, Bone Disorder, Depression, Hallucination, Decreased Appetite, Blood Pressure Increased, Dyspnoea, Nausea, Musculoskeletal Pain, Rash, Anxiety, Gingival Pain, Psychotic Disorder, Lung Disorder, Oral Pain, Dysuria, Pollakiuria, Memory Impairment, Feeling Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2004-10-30
End date: 2005-01-09
Pegasys
Pegasys
Dosage: dosage reported as one injection per week.
Indication: Hepatitis C
Start date: 2004-10-30
End date: 2005-01-09
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Telaprevir
Indication: Hepatitis C
Other drugs received by patient: Wellbutrin; Prozac
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: male
Reactions: Dysgeusia, Dyspnoea, Coagulopathy, Pulmonary Thrombosis, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-05-22
Ribavirin
Indication: Hepatitis C
Start date: 2012-05-22
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-07-18
Patient:
Reactions: Dyspnoea, Fatigue
Drug(s) suspected as cause:
Pegasys
Ribavirin
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-01
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-07-18
Patient:
Reactions: Dyspnoea, Blood Potassium Decreased, Anaemia, Abasia, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-06-01
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-06-01
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-06-01
Possible Ribavirin side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-17
Patient: male
Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash, Thyroid Function Test Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-13
Patient: male
Reactions: Dyspnoea, Dehydration, Dizziness, Ill-Defined Disorder, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-04-20
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-20
Telaprevir
Indication: Hepatitis C
Start date: 2012-04-20
End date: 2012-07-05
Possible Ribavirin side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 57 year old female, weighing 85.7 kg (188.6 pounds)
Reactions: Night Sweats, White Blood Cell Count Decreased, Dyspnoea, Wheezing, Chills, Haemorrhoids, Anaemia, Laceration, Pyrexia, Joint Stiffness, Fatigue, Diverticulum, RED Blood Cell Count Decreased, Arthralgia, Impaired Healing, Insomnia, Dizziness, Injury, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 mcg once a week
Indication: Hepatitis C
Pegasys
Dosage: 180 mcg once a week
Indication: Hepatitis C
Ribavirin
Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
Indication: Hepatitis C
Start date: 2011-09-04
Ribavirin
Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
Indication: Hepatitis C
Start date: 2011-11-07
Victrelis
Dosage: 200 mg 4 tabs three times a day orally
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
Other drugs received by patient: Echinacea; Citalopram Hydrobromide; Milk Thistle; Zolpidem; Vitamin E; Omeprazole; Allegra-D 12 Hour
Possible Ribavirin side effects in 52 year old female
Reported by a consumer/non-health professional from United States on 2012-07-05
Patient: 52 year old female
Reactions: Dyspnoea, Fall, Device Malfunction, Asthenia, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 mcg; qw
Indication: Hepatitis C
Start date: 2012-05-01
Ribavirin
Indication: Hepatitis C
Other drugs received by patient: Tranxene; Zofran; Synthroid; Effexor; Lisinopril; Paxil CR
Possible Ribavirin side effects in 56 year old male
Reported by a consumer/non-health professional from United Kingdom on 2012-07-04
Patient: 56 year old male, weighing 65.8 kg (144.7 pounds)
Reactions: Drug Dose Omission, White Blood Cell Count Decreased, Chest Discomfort, Dyspnoea, Decreased Activity, Musculoskeletal Pain, Rash, Headache, Full Blood Count Decreased, Haemoglobin Decreased, Fatigue, Affect Lability, Heart Rate Increased, Dizziness, Asthenia
Drug(s) suspected as cause:
Neupogen
Dosage: unk unk, 2 times/wk
Indication: White Blood Cell Count Decreased
Start date: 2011-04-29
Peginterferon Alfa-2A
Dosage: 180 mug, qwk
Indication: Hepatitis C
Start date: 2010-11-26
Ribavirin
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2010-11-26
Ribavirin
Dosage: 1000 mg, qd
Possible Ribavirin side effects in 44 year old female
Reported by a physician from Australia on 2012-07-03
Patient: 44 year old female, weighing 54.0 kg (118.8 pounds)
Reactions: Fatigue, Haematocrit Decreased, Pharyngeal Oedema, Vitreous Floaters, Dizziness, White Blood Cell Count Decreased, Back Pain, Dyspnoea, Swelling Face, Ill-Defined Disorder, Tremor, Haemoglobin Decreased, Vision Blurred, Neutropenia, Asthenia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
GS-5885 (Investigational Drug)
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-25
End date: 2012-03-31
GS-9451 (Investigational Drug)
Dosage: 200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-25
End date: 2012-03-31
Peginterferon Alfa-2A
Dosage: 180 mcg;qw;sc
Indication: Hepatitis C
Start date: 2012-01-25
End date: 2012-03-28
Ribavirin
Dosage: 1000 mg;qw;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-25
End date: 2012-03-31
Other drugs received by patient: Lysine; Pinetarsol; Cypromeptadine; Acidophilis; Loratadine; Metoclopranide; Mintec; Acetaminophen; Eumovate; Phenergan HCL; Arerius; Polaramine
Possible Ribavirin side effects in 56 year old female
Reported by a physician from United States on 2012-07-03
Patient: 56 year old female
Reactions: Weight Decreased, Capsule Physical Issue, Dyspnoea, Nausea, Anaemia, Headache, Rash, Dysgeusia, Fatigue, Asthenia, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.4 mcg ; 0.3 mcg
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
PEG-Intron
Dosage: 0.4 mcg ; 0.3 mcg
Indication: Hepatitis C
End date: 2008-10-07
PEG-Intron
Dosage: 0.4 mcg ; 0.3 mcg
Indication: Hepatitis C
Start date: 2011-08-17
End date: 2012-04-30
Ribavirin
Dosage: qd ; qd; 200 mg;qd
Indication: Hepatitis C
End date: 2009-10-07
Ribavirin
Dosage: qd ; qd; 200 mg;qd
Indication: Hepatitis C
Start date: 2011-08-17
End date: 2012-04-03
Ribavirin
Dosage: qd ; qd; 200 mg;qd
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-14
Other drugs received by patient: Procrit
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-29
Patient: male
Reactions: Nerve Injury, Cystitis Radiation, Pain, Cyst, Fatigue, Emotional Disorder, Pain in JAW, Abdominal Pain Lower, Back Pain, Dyspnoea, Blood Urine Present, Musculoskeletal Discomfort, Joint Injury, Full Blood Count Decreased, Irritability, Haemoglobin Decreased, Syncope, Arthralgia, Insomnia
Drug(s) suspected as cause:
Boceprevir
Indication: Hepatitis C
Start date: 2011-12-12
Pegasys
Indication: Hepatitis C
Start date: 2011-11-13
Ribavirin
Dosage: dose reduced
Administration route: Oral
Start date: 2012-01-25
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-13
Possible Ribavirin side effects in female
Reported by a pharmacist from United States on 2012-06-28
Patient: female
Reactions: Dyspnoea, Rash, Gait Disturbance
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mcg weekly subcutaneously
Indication: Hepatitis C
Start date: 2011-09-01
End date: 2012-05-01
Ribavirin
Dosage: 600 mcg twice a day by mouth
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-01
End date: 2012-05-01
Page 1 Next >>
|